Demise of Polymerase Chain Reaction/Electrospray Ionization-Mass Spectrometry as an Infectious Diseases Diagnostic Tool.

Abstract

Although there are several US Food and Drug Administration (FDA)-approved/cleared molecular microbiology diagnostics for direct analysis of patient samples, all are single target or panel-based tests. There is no FDA-approved/cleared diagnostic for broad microbial detection. Polymerase chain reaction (PCR)/electrospray ionization-mass spectrometry (PCR/ESI… (More)
DOI: 10.1093/cid/cix743

Topics

Cite this paper

@article{zenci2018DemiseOP, title={Demise of Polymerase Chain Reaction/Electrospray Ionization-Mass Spectrometry as an Infectious Diseases Diagnostic Tool.}, author={Volkan {\"O}zenci and Robin Patel and M{\aa}ns Ullberg and Kristoffer Str{\aa}lin}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2018}, volume={66 3}, pages={452-455} }